NanoVibronix Adds New U.S. Patent to ENvue Medical’s Expanding IP Arsenal

September 15, 2025

DENVER, Colo., Sep 15, 2025 (247marketnews.com)- NanoVibronix (NASDAQ:NAOV) continues to deepen its intellectual property moat with the issuance of a new U.S. patent granted to its wholly owned subsidiary, ENvue Medical Holdings LLC.

The United States Patent and Trademark Office awarded Patent No. 12,409,105 B2, titled “Insertion Device Positioning Guidance System and Method”, to ENvue Medical. The patent secures ENvue’s proprietary electromagnetic positioning technology used to guide the insertion of devices like feeding tubes, offering improved real-time visualization and increased procedural accuracy. The innovation is designed to reduce the risks associated with misplacement and improve clinical outcomes across enteral care and related procedures.

The newly issued patent adds to an already expanding intellectual property portfolio that supports ENvue’s position in the medical navigation space. As part of its broader strategy, NanoVibronix is focused on building durable technological differentiation in a market where procedural safety and efficiency are paramount.

This patent also reinforces ENvue Medical’s growing reputation as a leader in next-generation clinical navigation tools. With multiple U.S. and international patents now secured, the company continues to strengthen its competitive position in a specialized yet critical segment of healthcare technology.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (NAOV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.